Turner M W, Boulton P, Strobel S
Molecular Immunology Unit, Institute of Child Health, London, UK.
Clin Exp Allergy. 1995 May;25(5):448-55. doi: 10.1111/j.1365-2222.1995.tb01076.x.
The ability of four drugs with anti-allergic action to modulate the uptake of bystander protein, lactulose/rhamnose permeability ratios and mast cell activation was studied in rats presensitized with egg albumin in alum and challenged intraduodenally with the same antigen. Beclomethasone dipropionate (BDP) and nedocromil both significantly reduced the uptake of the bystander protein, bovine serum albumin (P < 0.002 and P > 0.02 respectively). BDP also significantly reduced sugar permeability (P < 0.01). In animals with elevated lactulose/rhamnose permeability ratios we confirmed our earlier observation of a significant correlation between levels of the specific mucosal mast cell protease Rat Chymase II (RChyII-previously known as RMCPII) and the sugar ratios. None of the drugs had any influence on the levels of mast cell protease II released following challenge and there was no correlation between the histological light microscopic appearance of the mast cells and the experimental treatment administered. Our results suggest that in the gut the pharmacological effect of anti-allergic drugs may be complex. Some, such as nedocromil, appear to act only on the mechanisms underlying increased protein uptake whereas others, such as BDP, appear to abrogate both increased protein uptake and increased sugar permeability.
在以明矾佐剂卵清蛋白致敏并经十二指肠给予相同抗原激发的大鼠中,研究了四种具有抗过敏作用的药物调节旁观者蛋白摄取、乳果糖/鼠李糖渗透率以及肥大细胞活化的能力。二丙酸倍氯米松(BDP)和奈多罗米均显著降低了旁观者蛋白牛血清白蛋白的摄取(分别为P < 0.002和P > 0.02)。BDP还显著降低了糖渗透率(P < 0.01)。在乳果糖/鼠李糖渗透率升高的动物中,我们证实了之前的观察结果,即特异性黏膜肥大细胞蛋白酶大鼠糜蛋白酶II(RChyII,以前称为RMCPII)水平与糖比率之间存在显著相关性。这些药物对激发后释放的肥大细胞蛋白酶II水平均无影响,肥大细胞的组织学光学显微镜外观与所给予的实验处理之间也无相关性。我们的结果表明,在肠道中,抗过敏药物的药理作用可能很复杂。一些药物,如奈多罗米,似乎仅作用于蛋白质摄取增加的潜在机制,而其他药物,如BDP,似乎既能消除蛋白质摄取增加,又能消除糖渗透率增加。